1. Home
  2. PSMT vs ADPT Comparison

PSMT vs ADPT Comparison

Compare PSMT & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PriceSmart Inc.

PSMT

PriceSmart Inc.

SELL

Current Price

$169.53

Market Cap

5.2B

ML Signal

SELL

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

SELL

Current Price

$24.95

Market Cap

4.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PSMT
ADPT
Founded
1994
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.5B
IPO Year
2005
2019

Fundamental Metrics

Financial Performance
Metric
PSMT
ADPT
Price
$169.53
$24.95
Analyst Decision
Buy
Strong Buy
Analyst Count
3
9
Target Price
★ $181.50
$29.81
AVG Volume (30 Days)
222.1K
★ 2.3M
Earning Date
10-26-2026
11-04-2026
Dividend Yield
★ 0.83%
N/A
EPS Growth
5.47
★ 63.89
EPS
★ 4.18
N/A
Revenue
★ $4,066,093,000.00
$276,976,000.00
Revenue This Year
$10.46
$5.94
Revenue Next Year
$11.62
$22.42
P/E Ratio
$40.60
★ N/A
Revenue Growth
12.33
★ 54.77
52 Week Low
$111.68
$12.00
52 Week High
$199.84
$30.74

Technical Indicators

Market Signals
Indicator
PSMT
ADPT
Relative Strength Index (RSI) 46.63 37.90
Support Level $166.32 $23.73
Resistance Level $177.50 $26.51
Average True Range (ATR) 3.62 1.44
MACD 0.16 -0.49
Stochastic Oscillator 46.79 0.43

Price Performance

Historical Comparison
PSMT
ADPT

About PSMT PriceSmart Inc.

Pricesmart Inc is principally engaged in operating U.S.-style membership shopping warehouse clubs that offer consumer goods at low prices. The company is headquartered in San Diego, California, United States, and operates stores in the Caribbean, Costa Rica, Panama, and other regions. The company's revenue consists of net warehouse club sales from merchandise sales, membership income from annual membership fees, export sales, and other income. Its operations consist of four reportable segments; Central America, the Caribbean, Colombia, and the United States. A majority of the company's revenue is derived from Central America.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: